Skip to main content

MoneyWorks4Me

Dr Reddys Laboratories informs about disclosure

20 Mar 2025 Evaluate
Dr Reddys Laboratories has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satish Reddy Kallam & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..